You are on Trendlyne United States. Click here to go to India website or make United States as your default

14.67 -0.10 (-0.68%)

Near 52W Low of $14.25

1.5M XNYS Volume

High volume today

XNYS 21 Mar, 2025 5:30 PM (EDT)

Avanos Medical Inc Key Metrics

Default
All financials are in USD Million and price data in USD
VIEW MORE
Medium Financial Strength
44.4 / 100
Mid Valuation
42.5 / 100
Technically Neutral
36.3 / 100
Mid-range Performer These stocks average quality, financial and technical aspects make them being considered by the investor who are not looking for high risk stocks. View Similar Embed DVM

Avanos Medical Inc Live Price Chart

Switch to TradingView
Fetching data ...

Forecaster - Analyst Share Price Target and Estimates

Revenue forecast

Created with Highcharts 7.2.2Dec '22Dec '23Dec '24Dec '25Dec '26600700800900Actual RevenueAvg. Estimate
Hit

Avanos Medical Inc's Revenue was higher than average estimate 3 times in past 3 years

Consensus Recommendation

2 ANALYST Recommendations
HOLD

Created with Highcharts 7.2.22Hold

The consensus recommendation from 2 analysts for Avanos Medical Inc is HOLD

Forecaster is a Premium Feature
You need to upgrade your subscription plan to access this feature
See what you get

Avanos Medical Inc Stock Analysis

Avanos Medical Inc stock analysis with key metrics, changes, and trends.

Avanos Medical Inc MetricVALUECHANGE %TRENDANALYSIS
Annual Revenue$687.8 M2.15%positive

Annual Revenue rose 2.15%, in the last year to $687.8 M. Its sector's average revenue growth for the last fiscal year was 8.73%.

Annual Net Profit$392.1 M534.47%negative

Annual Net Profit fell 534.47% in the last year to $392.1 M. Its sector's average net profit growth for the last fiscal year was 3.53%.

Price to Earning Ratio-1.72-negative

Price to Earning Ratio is -1.72, which is negative.

Stock Price$14.67-24.73%negative

Stock Price fell 24.73% and underperformed its sector by 31.16% in the past year.

Quarterly Revenue$179.6 M3.64%positive

Quarterly Revenue rose 3.64% YoY to $179.6 M. Its sector's average revenue growth YoY for the quarter was 8.57%.

Quarterly Net profit$397.3 M3883.81%negative

Quarterly Net profit fell 3,883.81% YoY to $397.3 M. Its sector's average net profit growth YoY for the quarter was 27.52%.

Debt to Equity Ratio0.21-positive

Debt to Equity Ratio of 0.21 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

Return on Equity(ROE)-37.98 %-37.98%negative

Return on Equity(ROE) for the last financial year was -37.98%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

Mutual Fund Holding76.49 %1.12%positive

Mutual Fund Holding increased by 1.12% in the last quarter to 76.49.

Promoter Share Holding1.47 %0.26%positive

Promoter Share Holding increased by 0.26% in the most recent quarter to 1.47%.

Interest Coverage Ratio-32.06-negative

Interest Coverage Ratio is -32.06, lesser than one. This means that it is unable to pay interests with its earnings (EBIT).

Institutional Holding94.00 %0%neutral

Institutional Holding remained the same in the last quarter at 94%.

VIEW LESS


Loading data..

Avanos Medical Inc - Company Profile

What does Avanos Medical Inc do?

Avanos Medical Inc is a United States-based company that develops and sells medical devices and related services globally. Its operating and reportable segment provides medical device products to healthcare providers and patients. The company has now changed two franchises: has combined Chronic Care and Pain Management franchises into a single commercial organization focused on the Digestive Health and Pain Management and Recovery product categories that generate its revenue from its Chronic Care franchise and in North America.

Avanos Medical Inc Management structure

All Gross Remunerations are in USD
Mr. Michael C. Greiner
Interim Chief Executive Officer
-
2025
Gross Remuneration
Year

Avanos Medical Inc Board of directors

All Gross Remunerations are in USD
Mr. Gary D. Blackford
Chairman of the Board
396.88 K
2024
Gross Remuneration
Year
Mr. Patrick J. O'Leary
Independent Director
292.5 K
2024
Gross Remuneration
Year
Dr. Julie A. Shimer, PhD
Independent Director
291.25 K
2024
Gross Remuneration
Year
Dr. Lisa C. Egbuonu-Davis, M.D.
Independent Director
276.25 K
2024
Gross Remuneration
Year
Mr. John P. Byrnes
Independent Director
241.25 K
2024
Gross Remuneration
Year
Ms. Indrani Lall Franchini, J.D.
Independent Director
140 K
2024
Gross Remuneration
Year

Avanos Medical Inc FAQ

How is Avanos Medical Inc today?
Avanos Medical Inc today is trading in the red, and is down by -0.68% at 14.67.
Avanos Medical Inc is currently trading down -0.68% on an intraday basis. In the past week the stock rose 1.45%. stock has been down -8.77% in the past quarter and fell -24.73% in the past year. You can view this in the overview section.